Bladder Pain, Interstitial Cystitis And The Move Toward Patient-Focused Drug Development
Executive Summary
Patients with the conditions experience the same symptoms, US FDA advisory committee concludes. Industry sponsors had advocated for combined trials, but panel did not agree with firms' recommendations on study duration and outcome measures.